Issue 82, 2021

“Covalent biosensing” enables a one-step, reagent-less, low-cost and highly robust assay of SARS-CoV-2

Abstract

We have established a new protocol for detecting severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) using a peptidomimetic to covalently detect a viral marker protease.

Graphical abstract: “Covalent biosensing” enables a one-step, reagent-less, low-cost and highly robust assay of SARS-CoV-2

Supplementary files

Article information

Article type
Communication
Submitted
09 Jul 2021
Accepted
11 Sep 2021
First published
22 Sep 2021

Chem. Commun., 2021,57, 10771-10774

“Covalent biosensing” enables a one-step, reagent-less, low-cost and highly robust assay of SARS-CoV-2

K. Zhang, J. Li, Z. Fan, H. Li and J. Xu, Chem. Commun., 2021, 57, 10771 DOI: 10.1039/D1CC03686F

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements